Osteoporotic Bone Regeneration via Plenished Biomimetic PLGA Scaffold with Sequential Release System
Small · 2024
DOI: 10.1002/smll.202310734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Jun-Kyu Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, CHA University, 335 Pangyo-ro, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea. Hauptthemen laut MEDLINE: Bone Regeneration, Polylactic Acid-Polyglycolic Acid Copolymer, Human Umbilical Vein Endothelial Cells, Tissue Scaffolds. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Korea Government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug…, Korea Government (the Ministry of Science and ICT, the Ministry of Health & Welfare), the Ministry of Science and ICT.
Abstract (Originalsprache)
Achieving satisfactory bone tissue regeneration in osteoporotic patients with ordinary biomaterials is challenging because of the decreased bone mineral density and aberrant bone microenvironment. In addressing this issue, a biomimetic scaffold (PMEH/SP), incorporating 4‐hexylresorcinol (4HR), and substance P (SP) into the poly(lactic‐go‐glycolic acid) (PLGA) scaffold with magnesium hydroxide (M) and extracellular matrix (E) is introduced, enabling the consecutive release of bioactive agents. 4HR and SP induced the phosphorylation of p38 MAPK and ERK in human umbilical vein endothelial cells (HUVECs), thereby upregulating VEGF expression level. The migration and tube‐forming ability of endothelial cells can be promoted by the scaffold, which accelerates the formation and maturation of the bone. Moreover, 4HR played a crucial role in the inhibition of osteoclastogenesis by interrupting the IκB/NF‐κB signaling pathway and exhibiting SP, thereby enhancing the migration and angiogenesis of HUVECs. Based on such a synergistic effect, osteoporosis can be suppressed, and bone regeneration can be achieved by inhibiting the RANKL pathway in vitro and in vivo, which is a commonly known mechanism of bone physiology. Therefore, the study presents a promising approach for developing a multifunctional regenerative material for sophisticated osteoporotic bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, CHA University, 335 Pangyo-ro, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Cambridge, MA, 02139, USA.
- Department of Orthopedic Surgery, CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, 13496, Republic of Korea.
ORCID-Profile: Jun-Kyu Lee, Da-Seul Kim, So-Yeon Park, Ji-Won Jung, Seung-Woon Baek, Tae-Keun Ahn, Dong Keun Han
Förderung
- Korea Government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug…
- Korea Government (the Ministry of Science and ICT, the Ministry of Health & Welfare)
- the Ministry of Science and ICT
Zitieren
APA
Lee, J. K., Kim, D. S., Park, S. Y., Jung, J. W., Baek, S. W., Lee, S., Kim, J. H., Ahn, T. K., & Han, D. K. (2024). Osteoporotic Bone Regeneration via Plenished Biomimetic PLGA Scaffold with Sequential Release System. Small. https://doi.org/10.1002/smll.202310734
Vancouver
Lee JK, Kim DS, Park SY, Jung JW, Baek SW, Lee S, et al. Osteoporotic Bone Regeneration via Plenished Biomimetic PLGA Scaffold with Sequential Release System. Small. 2024. doi:10.1002/smll.202310734
BibTeX
@article{Lee2024,
author = {Lee, Jun-Kyu and Kim, Da-Seul and Park, So-Yeon and Jung, Ji-Won and Baek, Seung-Woon and Lee, Semi and Kim, Jun Hyuk and Ahn, Tae-Keun and Han, Dong Keun},
title = {Osteoporotic Bone Regeneration via Plenished Biomimetic PLGA Scaffold with Sequential Release System},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202310734}
}
EUVIMED